Literature DB >> 1495960

Fluorescence-activated sorting of totipotent embryonic stem cells expressing developmentally regulated lacZ fusion genes.

S Reddy1, H Rayburn, H von Melchner, H E Ruley.   

Abstract

Murine embryonic stem (ES) cells were infected with a retrovirus promoter trap vector, and clones expressing lacZ fusion genes (LacZ+) were isolated by fluorescence-activated cell sorting (FACS). Of 12 fusion genes tested, 1 was repressed when ES cells were allowed to differentiate in vitro. Two of three lacZ fusion genes tested were passed into the germ line, indicating that FACS does not significantly affect stem cell totipotency. The pattern of lacZ expression observed in vivo was consistent with that seen in vitro. Both fusion genes were expressed in preimplantation blastulas. However, a fusion gene whose expression was unaffected by in vitro differentiation was ubiquitously expressed in day-10 embryos, while the other, which showed regulated expression in vitro, was restricted to cells located along the posterior neural fold, the optic chiasm, and within the fourth ventricle. These results demonstrate the utility of using promoter trap vectors in conjunction with fluorescence sorting to disrupt developmentally regulated genes in mice.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1495960      PMCID: PMC49575          DOI: 10.1073/pnas.89.15.6721

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice.

Authors:  G Friedrich; P Soriano
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

2.  Determinants of retrovirus gene expression in embryonal carcinoma cells.

Authors:  E Akgün; M Ziegler; M Grez
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

3.  Improved FACS-Gal: flow cytometric analysis and sorting of viable eukaryotic cells expressing reporter gene constructs.

Authors:  S N Fiering; M Roederer; G P Nolan; D R Micklem; D R Parks; L A Herzenberg
Journal:  Cytometry       Date:  1991

4.  Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines.

Authors:  A Bradley; M Evans; M H Kaufman; E Robertson
Journal:  Nature       Date:  1984 May 17-23       Impact factor: 49.962

5.  Local application of retinoic acid to the limb bond mimics the action of the polarizing region.

Authors:  C Tickle; B Alberts; L Wolpert; J Lee
Journal:  Nature       Date:  1982-04-08       Impact factor: 49.962

6.  Establishment in culture of pluripotential cells from mouse embryos.

Authors:  M J Evans; M H Kaufman
Journal:  Nature       Date:  1981-07-09       Impact factor: 49.962

7.  Integration-specific retrovirus expression in embryonal carcinoma cells.

Authors:  J Sorge; A E Cutting; V D Erdman; J W Gautsch
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  Transgenic mouse model of kidney disease: insertional inactivation of ubiquitously expressed gene leads to nephrotic syndrome.

Authors:  H Weiher; T Noda; D A Gray; A H Sharpe; R Jaenisch
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

9.  Retrovirus promoter-trap vector to induce lacZ gene fusions in mammalian cells.

Authors:  S Reddy; J V DeGregori; H von Melchner; H E Ruley
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  A promoter trap in embryonic stem (ES) cells selects for integration of DNA into CpG islands.

Authors:  D Macleod; R Lovell-Badge; S Jones; I Jackson
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

View more
  12 in total

1.  Stable and efficient cassette exchange under non-selectable conditions by combined use of two site-specific recombinases.

Authors:  Matthias Lauth; Fabio Spreafico; Kathrin Dethleffsen; Michael Meyer
Journal:  Nucleic Acids Res       Date:  2002-11-01       Impact factor: 16.971

2.  Activation of cryptic 3' splice sites within introns of cellular genes following gene entrapment.

Authors:  Anna B Osipovich; Erica K White-Grindley; Geoffrey G Hicks; Michael J Roshon; Christian Shaffer; Jason H Moore; H Earl Ruley
Journal:  Nucleic Acids Res       Date:  2004-05-20       Impact factor: 16.971

Review 3.  Functional genomics of the murine immune system.

Authors:  H E Ruley
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  Self-deleting retrovirus vectors for gene therapy.

Authors:  A P Russ; C Friedel; M Grez; H von Melchner
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site.

Authors:  A Choulika; V Guyot; J F Nicolas
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Selection for retroviral insertions into regulated genes.

Authors:  J A Gogos; W Lowry; M Karayiorgou
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Selective disruption of genes transiently induced in differentiating mouse embryonic stem cells by using gene trap mutagenesis and site-specific recombination.

Authors:  I S Thorey; K Muth; A P Russ; J Otte; A Reffelmann; H von Melchner
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

8.  Genomewide trapping of genes that encode secreted and transmembrane proteins repressed by oncogenic signaling.

Authors:  M Gebauer; H von Melchner; T Beckers
Journal:  Genome Res       Date:  2001-11       Impact factor: 9.043

9.  In vitro hematopoietic and endothelial potential of flk-1(-/-) embryonic stem cells and embryos.

Authors:  A C Schuh; P Faloon; Q L Hu; M Bhimani; K Choi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

10.  Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable.

Authors:  M R Pawlak; C A Scherer; J Chen; M J Roshon; H E Ruley
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.